Texas Attorney General Ken Paxton made headlines on Tuesday with a bold move, accusing the makers of Tylenol of deceptive marketing practices targeted towards pregnant women. In a lawsuit filed against Johnson & Johnson and Kenvue, Paxton alleged that the companies promoted unproven claims linking early exposure to acetaminophen, the active ingredient in Tylenol, to an increased risk of autism and other disorders.
The lawsuit, citing violations of Texas consumer protection laws, claimed that the companies concealed the potential dangers of acetaminophen to fetuses and young children while falsely marketing Tylenol as the only safe painkiller for pregnant women. Additionally, Paxton accused Johnson & Johnson of transferring liabilities related to Tylenol to Kenvue in an attempt to evade legal responsibilities.
Johnson & Johnson’s decision in 2021 to spin off its consumer health business into a separate entity, now known as Kenvue, was referenced in the lawsuit. The companies stated that all rights and liabilities associated with the sale of over-the-counter products, including Tylenol, now belong to Kenvue.
Paxton didn’t mince words, accusing Big Pharma of prioritizing profits over public health and knowingly endangering millions of people. He condemned Johnson & Johnson for trying to escape accountability by shifting liabilities to another company.
Acetaminophen, a widely used pain reliever and fever reducer in the U.S., has been the subject of conflicting studies regarding its potential link to autism. While some research suggests a possible association between Tylenol use during pregnancy and autism risk, many other studies have not found such a connection.
In response to the allegations, Kenvue reiterated the safety of acetaminophen for pregnant women, emphasizing the importance of treating high fevers and pain during pregnancy. The company vowed to defend itself against the claims and expressed concerns about the spread of misinformation that could impact women’s and children’s health.
Kenvue disclosed facing federal litigation over the autism claims, noting that some of these claims have been dismissed but are under appeal. The lawsuit filed in a Texas state court seeks damages for violations of the Deceptive Trade Practices-Consumer Protection Act and calls for the destruction of marketing materials that misrepresent Tylenol’s safety for pregnant women and children.
The legal battle between Texas and the makers of Tylenol is set to unfold in a jury trial in Panola County, a Republican-leaning region in East Texas. The state is seeking financial penalties for each violation of consumer protection laws and demanding the removal of misleading marketing materials from circulation.
As the controversy surrounding Tylenol and its alleged risks continues, the outcome of this lawsuit could have far-reaching implications for the pharmaceutical industry and public health awareness. Stay tuned for updates on this developing story.
